Chemotherapy for Generalized Infantile Myofibromatosis With Visceral Involvement

Research output: Contribution to journalArticle

8 Scopus citations


Infantile myofibromatosis (IM) is most commonly limited to cutaneous lesions that resolve spontaneously. However, generalized IM with visceral involvement, which has a reported mortality rate as high as 73%, has been successfully treated with a combination of methotrexate and vinblastine. Here we report the further efficacy of low-dose methotrexate and vinblastine in 2 pediatric patients with IM and visceral involvement and review the literature describing chemotherapy for these patients.

Original languageEnglish (US)
Pages (from-to)402-405
Number of pages4
JournalJournal of Pediatric Hematology/Oncology
Issue number5
StatePublished - Jul 1 2015

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Chemotherapy for Generalized Infantile Myofibromatosis With Visceral Involvement'. Together they form a unique fingerprint.

  • Cite this